Technical Analysis for ACHV - Achieve Life Sciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
8.87 | -4.31% | -0.40 |
ACHV closed down 4.31 percent on Thursday, August 13, 2020, on 66 percent of normal volume. It ran into resistance at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical ACHV trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | -4.31% | |
| Multiple of Ten Bearish | Other | -4.31% | |
| Wide Bands | Range Expansion | -4.31% | |
| Oversold Stochastic | Weakness | -4.31% | |
| Fell Below 200 DMA | Bearish | -9.86% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/06/2020
- Sector: Healthcare
- Industry: Biotechnology
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Biopharmaceutical Cancer Cancers Prostate Cancer Breast Cancer Non Small Cell Lung Cancer Oncolytics Biotech
Biopharmaceutical Cancer Cancers Prostate Cancer Breast Cancer Non Small Cell Lung Cancer Oncolytics Biotech
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 50.2 |
| 52 Week Low | 4.514 |
| Average Volume | 573,680 |
| 200-Day Moving Average | 10.82 |
| 50-Day Moving Average | 9.29 |
| 20-Day Moving Average | 10.71 |
| 10-Day Moving Average | 10.96 |
| Average True Range | 1.64 |
| ADX | 33.93 |
| +DI | 12.98 |
| -DI | 27.38 |
| Chandelier Exit (Long, 3 ATRs ) | 13.35 |
| Chandelier Exit (Short, 3 ATRs ) | 12.55 |
| Upper Bollinger Band | 13.67 |
| Lower Bollinger Band | 7.75 |
| Percent B (%b) | 0.19 |
| BandWidth | 55.20 |
| MACD Line | 0.27 |
| MACD Signal Line | 0.63 |
| MACD Histogram | -0.3664 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.89 | ||||
| Resistance 3 (R3) | 9.92 | 9.60 | 9.72 | ||
| Resistance 2 (R2) | 9.60 | 9.34 | 9.59 | 9.66 | |
| Resistance 1 (R1) | 9.24 | 9.18 | 9.08 | 9.21 | 9.61 |
| Pivot Point | 8.92 | 8.92 | 8.85 | 8.91 | 8.92 |
| Support 1 (S1) | 8.56 | 8.66 | 8.40 | 8.53 | 8.13 |
| Support 2 (S2) | 8.24 | 8.50 | 8.23 | 8.08 | |
| Support 3 (S3) | 7.88 | 8.24 | 8.02 | ||
| Support 4 (S4) | 7.85 |
